Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BISOPROLOL Cause Peripheral arterial occlusive disease? 54 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Peripheral arterial occlusive disease have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.2% of all adverse event reports for BISOPROLOL.

54
Reports of Peripheral arterial occlusive disease with BISOPROLOL
0.2%
of all BISOPROLOL reports
0
Deaths
50
Hospitalizations

How Dangerous Is Peripheral arterial occlusive disease From BISOPROLOL?

Of the 54 reports, 50 (92.6%) required hospitalization, and 2 (3.7%) were considered life-threatening.

Is Peripheral arterial occlusive disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 54 reports have been filed with the FAERS database.

What Other Side Effects Does BISOPROLOL Cause?

Dyspnoea (2,940) Bradycardia (2,535) Hypotension (2,504) Dizziness (2,153) Fall (2,011) Fatigue (1,983) Acute kidney injury (1,894) Malaise (1,602) Drug ineffective (1,486) Nausea (1,460)

What Other Drugs Cause Peripheral arterial occlusive disease?

NILOTINIB (319) METHOTREXATE (120) ADALIMUMAB (116) RIVAROXABAN (101) PONATINIB (90) IMATINIB (86) ASPIRIN (77) ATORVASTATIN (70) METOPROLOL (70) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)

Which BISOPROLOL Alternatives Have Lower Peripheral arterial occlusive disease Risk?

BISOPROLOL vs BISOPROLOL\BISOPROLOL BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE BISOPROLOL vs BIVALIRUDIN BISOPROLOL vs BLEOMYCIN BISOPROLOL vs BLINATUMOMAB

Related Pages

BISOPROLOL Full Profile All Peripheral arterial occlusive disease Reports All Drugs Causing Peripheral arterial occlusive disease BISOPROLOL Demographics